Spero Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spero Therapeutics, Inc. has filed 508 SEC EDGAR filings since 21 Mar 2017

SEC filing history

Showing 251-275 of 508 matching filings.

Per page
25
Current page
11
4

PRIMARY DOCUMENT

Filing date
27 Aug 2021
Reporting date
26 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Aug 2021
Reporting date
20 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Aug 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-406258

D filing

Filing date
14 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90168

SC 13G SPERO THERAPEUTICS, INC.

Filing date
09 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38266

DEF 14A

Filing date
06 Jul 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38266

PRE 14A

Filing date
25 Jun 2021
Reporting date
17 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38266

10-Q Q1 2021

Filing date
06 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
EFFECT File 333-254170

EFFECT filing

Filing date
29 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-38266

10-K/A

Filing date
23 Mar 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
17 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-254173

S-8

Filing date
11 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .